Organovo Holdings Inc. (NASDAQ: ONVO) Stock Information | RedChip

Organovo Holdings Inc. (NASDAQ: ONVO) Listen to this Section


$0.57
+0.0120 ( +2.15% ) 44.9K

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

Market Data


Open


$0.57

Previous close


$0.56

Volume


44.9K

Market cap


$8.69M

Day range


$0.55 - $0.60

52 week range


$0.50 - $2.05

Insider Ownership Transactions

Total Amount Purchased: -196,070.00 | $ -111,759.90

Date Type Amount Purchased Purchaser
2024-08-09 Sale -19607.00 Gobel David
2024-08-09 Sale -19607.00 Milhous Alison Tjosvold
2024-08-09 Sale -19607.00 STERN ADAM K
2024-08-09 Sale -19607.00 Joshi Vaidehi
2024-08-09 Sale -19607.00 Cohen Douglas Jay
2024-08-07 Sale -19607.00 Murphy Keith
2023-11-17 Sale -19607.00 Milhous Alison Tjosvold
2023-11-17 Sale -19607.00 Cohen Douglas Jay
2023-11-17 Sale -19607.00 Murphy Keith
2023-11-17 Sale -19607.00 Gobel David

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 11 Aug 09, 2024
4 Insider transactions 1 Aug 09, 2024
4 Insider transactions 1 Aug 09, 2024
4 Insider transactions 1 Aug 09, 2024
4 Insider transactions 1 Aug 09, 2024
4 Insider transactions 1 Aug 09, 2024
4 Insider transactions 1 Aug 07, 2024
10-q Quarterly Reports 63 Aug 05, 2024
10-k/a Quarterly Reports 3 Jul 26, 2024
8-k 8K-related 11 Jul 24, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.